Iranian Journal of Cancer Prevention
 |
|
Iranian Journal of Cancer Prevention |
|
|
Instructions For AuthorType of Articles Original Articles: Should contain title page, abstract, keywords, introduction, materials and methods, results, discussion, acknowledgment, references, tables, and figures, enumerated from the title page. The length of the text should be limited to 4500 words excluding the references. Case Reports and Brief Reports: Should not exceed 2000 words. Both should include abstract, keywords, case presentation, discussion, acknowledgment, references, and 1 to 4 figures. Necessary documentations of the case(s) like pathology and laboratory test reports should be included in the submission package. Brief reports should not have more than one figure and/or table. Clinical Trials: Should contain patients’ informed consent forms and the approval of the bioethics committee of the corresponding institution and trial registration identification. If your research article reports the results of controlled health care intervention, please list your trial registry, along with the unique identifying number e.g. Trial registration: Current Controlled Trials ISRCTN77825547.Please note that there should be no space between the letters and numbers of your trial registration number. Review Articles: Should be requested by the editor, but "Iranian Journal of Cancer Prevention" will also accept submitted reviews. The authors of review articles are invited to contact the Editorial Office before preparing a review article. Both solicited and unsolicited review articles are subjected to editorial review such as the original papers. History of Contemporary Medicine in Iran: Manuscripts narrating the history of modern medicine in Iran, the outstanding scientists’ contribution to its progress, and the improvement of our healthcare system over the past decades are important to us and are welcome. Letters to the Editor: "Iranian Journal of Cancer Prevention" accepts letters to the editor. Letters, less than 500 words, should discuss articles published in the journal during the previous six months. Letters will under go peer-review processing and will be edited for clarity. Commentary: "Iranian Journal of Cancer Prevention" accepts the comment(s) from the experts in the shape of Commentary Letter not more than 1200 words. Case Series: It is included all of the reports about the special diagnosis or treatment and new procedure in some limited cases with good results but not confirmed yet internationally as a global choice. It should be not exceed more than 2500. Structure of Articles Title Page: Should contain title which should include the study design; author(s) information such as the first name, last name, highest academic degree, and affiliation. The whole information on the title page should not exceed 50 characters, including spaces; and name and address of the corresponding author to whom reprint requests should be sent. Abstract: Should contain background, methods, results, and conclusion sections separately. The objective of the study, findings (including its statistical significance), and the conclusion made on the basis of the findings should be clearly presented. Abstract is not necessary for case reports, while review articles should have an abstract. Nevertheless, the length of an abstract should be less than 250 words (150 words for case reports).Authors needs to be careful that the abstract reflects the content of the article accurately. Keywords: Each submitted article should contain three to five keywords. Keywords will assist indexers in cross indexing the article as they are published with abstract. Use terms from the Medical Subject Headings (MeSH) list of index medicus (http://www.ncbi.nlm.nih.gov/mesh). Introduction: This should summarize the purpose and the rationale for the study. It should neither review the subject xtensively nor should it have data or conclusions of the study. Materials and Methods: This should include exact method or observation or experiment. If an apparatus is used, its manufacturer’s name and address should be given in parenthesis. If the method is established, give reference but if the method is new, give enough information so that another author is able to perform it. If a drug is used, its generic name, dose and route of administration must be given. For patients, age, sex with mean age ± standard deviation must be given. Statistical method must be mentioned and specify any general computer programme used. The Info system used should be clearly mentioned. Results: It must be presented in the form of text, tables and illustrations. The contents of the tables should not be all repeated in the text. Instead, a reference to the table number may be given. Long articles may need sub-headings within some sections (especially the Results and Discussion parts) to clarify their contents. Discussion: This should emphasize the present findings and the variations or similarities with other work done in the field by other workers. The detailed data should not be repeated in the discussion again. Emphasize the new and important aspects of the study and the conclusions that follow from them. It must be mentioned whether the hypothesis mentioned in the article is true, false or no conclusions can be derived. Acknowledgements: All contributors who do not meet the criteria for authorship should be covered in the acknowledgement section. It should include persons who provided technical help, writing assistance and departmental head that only provided general support. Financial and material support should also be acknowledged. Conflict of Interest: Authors must acknowledge and declare any sources of funding and potential conflicting interest, such as receiving funds or fees by, or holding stocks and shares in, an organization that may profit or lose through publication of your paper. Declaring a competing interest will not lead to automatic rejection of the paper, but we would like to be made aware of it. Authors' Contribution: Corresponding author must write that which author do what, ex: AM designed the study, analyzed the data and wrote the paper. KL contributed to the data entry, literature review and writing-up process. AS and DE contributed to the study design and analysis. All authors read and approved the final manuscript. Figures: Should be used only in case they enhance understanding of the text, with high quality in limited numbers. Each figure should have a label showing the figure number, title, and title of the manuscript, which should be placed below. Illustrations should be numbered as cited in the respective order in the text. References: The authors are responsible for the accuracy of references, which must be numbered respectively in the order of citation in the text (Vancouver style). Reference citations should come within text marked by numbers in brackets. Personal communications and unpublished data including manuscripts submitted but not yet accepted for publication should not be used as a reference; however, they may be placed in parentheses in the text. Journal titles should be abbreviated according to Index Medicus. Inclusive page numbers should be given for all references. When there are six or less authors, surnames and initials of all authors should be mentioned. In the case of seven or more authors, the names of the first six authors followed by et al should be written. Links: Web links and URLs should be included in the reference list. They should be provided in full, including both the title of the site and the URL, in the following format: The Concept of Palliative care among Iranian People [http://palliative care.iran.jax.org/mtbwi/index.do] IJCP reference style Article within a journal Akbari ME, Mofid B, Esna Ashari F, Sohrabi MR, Abadi AR, Mehrabian AA, et al.: Colorectal cancer prevalence according to survival data in Iran 2007. Iran J Cancer Prev 2009; 2(1):15-8. Article within a journal supplement In press article Published abstract Article within conference proceedings Complete book Monograph or book in a series Book with institutional author MD and PhD thesis Link / URL Proof Reading: A computer printout is sent to the corresponding author for proof reading before publication in order to avoid any mistakes. Corrections should be marked clearly and sent immediately to the Journal office. Abbreviations and symbols: Use only standard abbreviations. Avoid using them in the title and abstract. The full term for which an abbreviation stands should precede its first use in the text unless it is a standard unit of measurement. Free issues: Corresponding author will be supplied with at least 4 free issues. Page charges: There are no charges for publication in this Journal. Disposal of material: Once published, all copies of the manuscript, correspondence and artwork will be held for 6 months before disposal. Submission: Manuscripts must have been written in English. Also the manuscript must have confirm letter that is assumed manuscripts are exclusively submitted to IJCP and have not been previously published elsewhere (except in the form of an abstract or as part of a published lecture, review or thesis), and are not under consideration by any other journal. In the covering letter one author should be specified as the “corresponding author” and all other authors should personally sign the covering letter. Authors are responsible for all statements made in their work. The editorial board has the right to insert any necessary changes so that the manuscript is harmonized with the editorial framework of the journal. Accepted manuscripts are the properties of "Iranian Journal of Cancer Prevention" All submissions to the IJCP should contain a completed copy of signed covered letter containing the copyright agreement. 1) Mail submission: The corresponding author should mail the original copy along with two review copies to: 2) Online submission: The peer review system enables authors to submit their papers online and track its progress via web. For online submission, authors should refer to the website at www.ijcp.ir and register. Authors should carefully read the users’ online manual before submitting the paper. Manuscripts should be submitted in Microsoft Word or Rich Text Format (RTF). The entire manuscript should be submitted in a single file. 3 Email: info@ijcp.ir The Final Checklist |
|
All Rights Reserved to Iranian Journal of Cancer Prevention Powered by Health Researchers R&D Institute |